| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Innovative Pharmaceutical Biotech Limited (HK: 0399)
0399 Technical Analysis
5
| As on 12th Sep 2025 0399 STOCK Price closed @ 0.44 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.21 & Strong Buy for SHORT-TERM with Stoploss of 0.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0399STOCK Price
| Open | 0.52 | Change | Price | % |
| High | 0.52 | 1 Day | -0.08 | -15.38 |
| Low | 0.40 | 1 Week | -0.08 | -15.38 |
| Close | 0.44 | 1 Month | -0.09 | -16.98 |
| Volume | 106827520 | 1 Year | 0.24 | 120.00 |
| 52 Week High 0.66 | 52 Week Low 0.15 | ||||
HK Hong Kong Most Active Stocks
| 0020 | 2.26 | 7.11% |
| 0020-OL | 2.26 | 7.11% |
| CSHK100 | 2354.52 | 1.46% |
| 2007 | 0.66 | 6.45% |
| 1918 | 1.87 | 8.72% |
| 6666 | 1.11 | 20.65% |
| 1341 | 0.28 | -6.67% |
| 43 | 1.14 | 0.00% |
| 3377 | 0.17 | 13.33% |
| 0813 | 0.42 | 2.44% |
HK Hong Kong Top Gainers Stocks
HK Hong Kong Top Losers Stocks
| 0399 Daily Charts |
0399 Intraday Charts |
Whats New @ Bazaartrend |
0399 Free Analysis |
|
|
0399 Important Levels Intraday
| RESISTANCE | 0.67 |
| RESISTANCE | 0.60 |
| RESISTANCE | 0.55 |
| RESISTANCE | 0.51 |
| SUPPORT | 0.37 |
| SUPPORT | 0.33 |
| SUPPORT | 0.28 |
| SUPPORT | 0.21 |
0399 Forecast September 2025
| 4th UP Forecast | 0.52 |
| 3rd UP Forecast | 0.49 |
| 2nd UP Forecast | 0.48 |
| 1st UP Forecast | 0.46 |
| 1st DOWN Forecast | 0.42 |
| 2nd DOWN Forecast | 0.4 |
| 3rd DOWN Forecast | 0.39 |
| 4th DOWN Forecast | 0.36 |
0399 Weekly Forecast
| 4th UP Forecast | 0.46 |
| 3rd UP Forecast | 0.45 |
| 2nd UP Forecast | 0.45 |
| 1st UP Forecast | 0.45 |
| 1st DOWN Forecast | 0.43 |
| 2nd DOWN Forecast | 0.43 |
| 3rd DOWN Forecast | 0.43 |
| 4th DOWN Forecast | 0.42 |
0399 Forecast2025
| 4th UP Forecast | 1.58 |
| 3rd UP Forecast | 1.21 |
| 2nd UP Forecast | 0.99 |
| 1st UP Forecast | 0.76 |
| 1st DOWN Forecast | 0.12 |
| 2nd DOWN Forecast | -0.11 |
| 3rd DOWN Forecast | -0.33 |
| 4th DOWN Forecast | -0.7 |
Innovative Pharmaceutical Biotech Limited ( HK Hong Kong Symbol : 0399 )
Sector : Consumer Defensive And Other Stocks in Same Sector
Sector : Consumer Defensive And Other Stocks in Same Sector
0399 Business Profile
Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trading of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products and Research and Development. It is also involved in the funds/securities investment; research, development, and commercialization of oral insulin products; distribution of bio-industrial products; and provision of genetic testing services. The company was formerly known as United Gene High-Tech Group Limited and changed its name to Innovative Pharmaceutical Biotech Limited in September 2015. Innovative Pharmaceutical Biotech Limited is headquartered in Sheung Wan, Hong Kong. Address: West Tower Shun Tak Centre, Sheung Wan, Hong Kong
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service